Exploring Pancreatic Metabolism and Malignancy

This book comprehensively describes the association between metabolic syndrome and pancreatic cancer progression, and the mechanism of action and target definition with a view to drug discovery. Metabolic syndrome, which includes adnominal obesity, hypertension, dyslipidemia, and hyperglycemia, has...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Nagaraju, Ganji Purnachandra (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), BM Reddy, Aramati (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Singapore : Springer Singapore : Imprint: Springer, 2019.
Έκδοση:1st ed. 2019.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 04542nam a2200541 4500
001 978-981-32-9393-9
003 DE-He213
005 20191123141018.0
007 cr nn 008mamaa
008 191123s2019 si | s |||| 0|eng d
020 |a 9789813293939  |9 978-981-32-9393-9 
024 7 |a 10.1007/978-981-32-9393-9  |2 doi 
040 |d GrThAP 
050 4 |a RC261-271 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
072 7 |a MJCL  |2 thema 
082 0 4 |a 614.5999  |2 23 
245 1 0 |a Exploring Pancreatic Metabolism and Malignancy  |h [electronic resource] /  |c edited by Ganji Purnachandra Nagaraju, Aramati BM Reddy. 
250 |a 1st ed. 2019. 
264 1 |a Singapore :  |b Springer Singapore :  |b Imprint: Springer,  |c 2019. 
300 |a XII, 268 p. 35 illus., 29 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a Chapter 1. Biology of pancreas and possible diseases -- Chapter 2. Pancreatitis: Clinical aspects of inflammatory phenotypes -- Chapter 3. Diabetes and Pancreatic Cancer - A Bidirectional Relationship Perspective -- Chapter 4. Metabolic Adaptations in Diabetes Mellitus and Cancer -- Chapter 5. Role of Mitochondria in pancreatic metabolism, diabetes and cancer -- Chapter 6. Targeting Mitochondrial Enzymes in Pancreatic Cancer -- Chapter 7. Diabetes with Pancreatic ductal adenocarcinoma -- Chapter 8. Role of Inflammatory Cytokines in the initiation and progression of Pancreatic Cancer -- Chapter 9. Perspectives and molecular understanding of pancreatic cancer stem cells -- Chapter 10. The Role of Hypoxia Inducible Factor-1α in Pancreatic Cancer and Diabetes Mellitus -- Chapter 11. Role of Heat shock protein 90 in Diabetes and Pancreatic Cancer Management -- Chapter 12. Insulin resistance is a common core tethered to diabetes and pancreatic cancer risk -- Chapter 13. Immunotherapy for Diabetogenic Pancreatitis and Pancreatic Cancer: An Update -- Chapter 14. Exosomes: Mediators and Therapeutic Targets of Diabetes and Pancreatic Cancer -- Chapter 15. Methods and models in exploring pancreatic functions. 
520 |a This book comprehensively describes the association between metabolic syndrome and pancreatic cancer progression, and the mechanism of action and target definition with a view to drug discovery. Metabolic syndrome, which includes adnominal obesity, hypertension, dyslipidemia, and hyperglycemia, has recently been shown to play an important role in the etiology and progression of various cancers. Further, obesity and diabetes have been associated with an increased incidence of gastric cancers. The book reviews the key biological mechanisms underlying the association between metabolic dysregulation, including obesity-associated enhancement of growth factor signaling, inflammation, and perturbation in pancreatic cancer cell growth and metastasis. It also illustrates the role of the inflammatory signaling pathway in metabolic diseases as well as tumor growth and explores the potential of these pathways as the rational targets for pancreatic cancer therapy. Lastly, the book offers a comprehensive description of the challenges associated with diabetes and pancreatic cancer therapy. 
650 0 |a Cancer research. 
650 0 |a Metabolic diseases. 
650 0 |a Human physiology. 
650 0 |a Diabetes. 
650 0 |a Immunology. 
650 1 4 |a Cancer Research.  |0 http://scigraph.springernature.com/things/product-market-codes/B11001 
650 2 4 |a Metabolic Diseases.  |0 http://scigraph.springernature.com/things/product-market-codes/H33118 
650 2 4 |a Human Physiology.  |0 http://scigraph.springernature.com/things/product-market-codes/B13004 
650 2 4 |a Diabetes.  |0 http://scigraph.springernature.com/things/product-market-codes/H33045 
650 2 4 |a Immunology.  |0 http://scigraph.springernature.com/things/product-market-codes/B14000 
700 1 |a Nagaraju, Ganji Purnachandra.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a BM Reddy, Aramati.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9789813293922 
776 0 8 |i Printed edition:  |z 9789813293946 
776 0 8 |i Printed edition:  |z 9789813293953 
856 4 0 |u https://doi.org/10.1007/978-981-32-9393-9  |z Full Text via HEAL-Link 
912 |a ZDB-2-SBL 
950 |a Biomedical and Life Sciences (Springer-11642)